Exogenous adenosine has an even more pronounced negative chronotropic and dromotropic effect than endogenous adenosine, making the appearance of advanced atrioventricular blocks more frequent with adenosine than with dipyridamole for equivalent doses. Adenosine is a direct alternative to dipyridamole – the prototype of vasodilator adenosinergic stress. Like dipyridamole, antianginal drugs lower the sensitivity of adenosine stress echocardiography, whereas concomitant therapy with oral dipyridamole potentiates the cardiovascular effects of adenosine. The safety record and short half-life make adenosine especially indicated in patients with severe aortic stenosis or elderly patients, who may be especially vulnerable to complications during dipyridamole or dobutamine stress. In some countries an additional limitation of adenosine is its exorbitant cost: in the United States, adenosine costs $179, dipyridamole $95, and dobutamine $1 per examination. However in Europe, it is also possible to obtain a galenic formulation of adenosine from hospital pharmacies at a very low cost of around €1. Possibly, more expensive third-generation selective A2A agonists may find a selective indication in patients with moderate and severe chronic obstructive pulmonary disease, who have an indication for stress imaging and may want to avoid adenosine-induced bronchoconstriction and respiratory compromise – although in these patients the use of the bronchodilator dobutamine might be more reasonable.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
- Myocardial Perfusion Imaging
- Coronary Flow Reserve
- Stress Echocardiography
- Myocardial Perfusion Scintigraphy
- Adenosine Stress
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Verani MS, Mahmarian JJ, Hixson JB, et al (1990) Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise. Circulation 82:80–87
Picano E (1989) Dipyridamole-echocardiography test: historical background and physiologic basis. Eur Heart J 10:365–376
Arlington Medical Resources (2006) The myocardial perfusion market guide (US and Europe). Arlington Medical Resources, Arlington, VA
Verani MS (1991) Adenosine thallium 201 myocardial perfusion scintigraphy. Am Heart J 122:269–278
Bateman TM (2004) Cardiac positron emission tomography and the role of adenosine pharmacologic stress. Am J Cardiol 94:19D–24D
Paetsch I, Jahnke C, Wahl A, et al (2004) Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation 110:835–842
Zoghbi WA (1991) Use of adenosine echocardiography for diagnosis of coronary artery disease. Am Heart J 122:285–292
Djordjevic-Dikic AD, Ostojic MC, Beleslin BD, et al (1996) High-dose adenosine stress echocardiography for noninvasive detection of coronary artery disease. J Am Coll Cardiol 28:1689–1695
Lafitte S, Masugata H, Peters B, et al (2001) Accuracy and reproducibility of coronary flow rate assessment by real-time contrast echocardiography: in vitro and in vivo studies. J Am Soc Echocardiogr 14:1010–1019
Caiati C, Zedda N, Montaldo C, et al (1999) Contrast-enhanced transthoracic second harmonic echo Doppler with adenosine: a noninvasive, rapid and effective method for coronary flow reserve assessment. J Am Coll Cardiol 34:122–130
Sicari R, Nihoyannopoulos P, Evangelista A, et al; European Association of Echocardiography (2008) Stress echocardiography consensus statement of the European Association of Echocardiography. Eur J Echocardiogr 9:415–437
Korosoglou G, Dubart AE, DaSilva KG Jr, et al (2006) Real-time myocardial perfusion imaging for pharmacologic stress testing: added value to single photon emission computed tomography. Am Heart J 151:131–138
Cerqueira MD (2004) The future of pharmacologic stress: selective A2A adenosine receptor agonists. Am J Cardiol 94:33D–40D
Iskandrian AE, Bateman TM, Belardinelli L, Blackburn B, Cerqueira MD, Hendel RC, Lieu H, Mahmarian JJ, Olmsted A, Underwood SR, Vitola J, Wang W; ADVANCE MPI Investigators. (2007) Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol 14:645–658
Fredholm BB, Abbracchio M P, Burnstock G, et al (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143–156
Drury AN, Szent-GyorgyA (1929) The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol 68:213–237
MacCollin M, Peterfreund R, MacDonald M, et al (1994) Mapping of a human A2a adenosine receptor (ADORA2) to chromosome 22. Genomics 20:332–333
Andreassi MG, Foffa I, Gherardi S, et al (2008) Genetic polymorphism in the adenosine A2A receptor affects coronary flow reserve response in non-ischemic dilated cardiomyopathy. Eur Heart J 29, Suppl 1
Conradson T-BG, Dixon CMS, Clarke B, et al (1987) Cardiovascular effects of infused adenosine in man: potentiation by dipyridamole. Acta Physiol Scand 129:387–391
Biaggioni I, Olafsson B, Robertson RM, et al (1987) Cardiovascular and respiratory effects of adenosine in conscious man. Evidence for chemoreceptor activation. Circ Res 61:779–786
Iskandrian AS, Verani MS, Heo J (1994) Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease. J Nucl Cardiol 1:94–111
Beleslin BD, Ostojic M, Djordjevic-Dikic A, et al (1997) Coronary vasodilation without myocardial erection. Simultaneous haemodynamic, echocardiographic and arteriographic findings during adenosine and dipyridamole infusion. Eur Heart J 18:1166–1174
Tawa CB, Baker WB, Kleiman NS, et al (1996) Comparison of adenosine echocardiography, with and without isometric handgrip, to exercise echocardiography in the detection of ischemia in patients with coronary artery disease. J Am Soc Echocardiogr 9:33–43
Miyazono Y, Kisanuki A, Toyonaga K, et al (1998) Usefulness of adenosine triphosphateatropine stress echocardiography for detecting coronary artery stenosis. Am J Cardiol 82:290–294
Pizzuto F, Voci P, Mariano E, et al (2001) Assessment of flow velocity reserve by transthoracic Doppler and venous adenosine infusion, before and after left anterior descending coronary stenting. J Am Coll Cardiol 38:155–162
Wilson R F, Wyche K, Christensen B V, et al (1990) Effects of adenosine on human coronary arterial circulation. Circulation 82:1595–1606
Kern M, Deligonul U, Tatineni S, et al (1991) Intravenous adenosine: continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease. J Am Coll Cardiol 18:718–729
Cerqueira MD,Verani MS, Schwaiger M, et al (1994) Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol 23:384–389
Martin T W, Seaworth JF, Johns J P, et al (1992) Comparison of adenosine, dipyridamole, and dobutamine in stress echocardiography. Ann Intern Med 116:190–196
Lette J, Tatum JL, Fraser S, et al (1995) Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study. J Nucl Cardiol 2:3–17
Picano E, Marini C, Pirelli S, et al (1992) Safety of intravenous high-dose dipyridamole echocardiography. The Echo-Persantine International Cooperative Study Group. Am J Cardiol 70:252–258
Picano E, Mathias W Jr, Pingitore A, et al on behalf of the EDIC study group (1994) Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, large-scale, multicenter trial. Lancet 344:1190–1192
Zoghbi WA, Cheirif J, Kleiman NS, et al (1991) Diagnosis of ischemic heart disease with adenosine echocardiography. J Am Coll Cardiol 18:1271–1279
Edlund A, Albertsson P, Caidahl K, et al (1991) Adenosine infusion to patients with ischaemic heart disease may provoke left ventricular dysfunction detected by echocardiography. Clin Physiol 11:477–488
Marwick T, Willemart B, D'Hondt AM, et al (1993) Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography. Circulation 87:345–354
Case RA, Buckmire R, McLaughlin D P, et al (1994) Physiological assessment of coronary artery disease and myocardial viability in ischemic syndromes using adenosine echocardiography. Echocardiography 11:133–143
Takeishi Y, Chiba J, Abe S, et al (1994) Adenosine-induced heterogeneous perfusion accompanies myocardial ischemia in the presence of advanced coronary artery disease. Am Heart J 127:1262–1268
Heijenbrok-Kal MH, Fleischmann KE, Hunink MG (2007) Stress echocardiography, stress single-photon-emission computed tomography and electron beam computed tomography for the assessment of coronary artery disease: a meta-analysis of diagnostic performance. Am Heart J 154:415–423
Djordjevic-Dikic A, Ostojic M, Beleslin B, et al (2003) Low-dose adenosine stress echocardiography: detection of myocardial viability. Cardiovasc Ultrasound 1:7
Hachamovitch R, Hayes S W, Friedman JD, et al (2005) A prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy. J Am Coll Cardiol 45:722–729
Jahnke C, Nagel E, Gebker R, et al (2007) Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 115:1769–1776
Patsilinakos S P, Kranidis AI, Antonelis I P, et al (1999) Detection of coronary artery disease in patients with severe aortic stenosis with noninvasive methods. Angiology 50:309–317
Anthopoulos L P, Bonou MS, Kardaras FG, et al (1996) Stress echocardiography in elderly patients with coronary artery disease: applicability, safety and prognostic value of dobutamine and adenosine echocardiography in elderly patients. J Am Coll Cardiol 28:52–59
Thomas GS, Tammelin BR, Schiffman GL, et al (2008) Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled trial (RegCOPD trial). J Nucl Cardiol 15:319–328
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Picano, E., Ostojic, M., Citro, R. (2009). Adenosine Stress Echocardiography. In: Picano, E. (eds) Stress Echocardiography. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-76466-3_14
Download citation
DOI: https://doi.org/10.1007/978-3-540-76466-3_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-76465-6
Online ISBN: 978-3-540-76466-3
eBook Packages: MedicineMedicine (R0)